ID
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
sequence | ner_tags
sequence |
---|---|---|---|---|---|
NCT00432094 | 1:11:chronic_disease | arrhythmia | 1 | [
"arrhythmia"
] | [
2
] |
NCT02085941 | 36:51:cancer,60:70:cancer | must have histologically confirmed malignant tumor that is metastatic or unresectable and for which standard curative or palliative measures do not exist or are no longer effective | 1 | [
"must",
"have",
"histologically",
"confirmed",
"malignant",
"tumor",
"that",
"is",
"metastatic",
"or",
"unresectable",
"and",
"for",
"which",
"standard",
"curative",
"or",
"palliative",
"measures",
"do",
"not",
"exist",
"or",
"are",
"no",
"longer",
"effective"
] | [
0,
0,
0,
0,
3,
3,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02015390 | 35:50:cancer | Disseminated and/or nonresectable malignant tumor involving bone | 1 | [
"Disseminated",
"and/or",
"nonresectable",
"malignant",
"tumor",
"involving",
"bone"
] | [
0,
0,
0,
3,
3,
0,
0
] |
NCT03121352 | 46:56:cancer | willing to undergo a preliminary biopsy of a metastatic focus for research purposes | 1 | [
"willing",
"to",
"undergo",
"a",
"preliminary",
"biopsy",
"of",
"a",
"metastatic",
"focus",
"for",
"research",
"purposes"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0
] |
NCT03109041 | 13:23:cancer | Patient has metastatic disease | 1 | [
"Patient",
"has",
"metastatic",
"disease"
] | [
0,
0,
3,
0
] |
NCT02496208 | 39:49:cancer | Histologically confirmed diagnosis of metastatic | 1 | [
"Histologically",
"confirmed",
"diagnosis",
"of",
"metastatic"
] | [
0,
0,
0,
0,
3
] |
NCT02166190 | 1:11:cancer | metastatic disease | 1 | [
"metastatic",
"disease"
] | [
3,
0
] |
NCT02143726 | 6:16:cancer | have metastatic disease or locally advanced unresectable disease | 1 | [
"have",
"metastatic",
"disease",
"or",
"locally",
"advanced",
"unresectable",
"disease"
] | [
0,
3,
0,
0,
0,
0,
0,
0
] |
NCT02064673 | 26:36:cancer | no sign of lymph node or metastatic disease | 1 | [
"no",
"sign",
"of",
"lymph",
"node",
"or",
"metastatic",
"disease"
] | [
0,
0,
0,
0,
0,
0,
3,
0
] |
NCT01954173 | 15:25:cancer | Patients with metastatic disease outside of the pelvis | 1 | [
"Patients",
"with",
"metastatic",
"disease",
"outside",
"of",
"the",
"pelvis"
] | [
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02754544 | 14:29:treatment,108:141:cancer | undergoing a tumor resection at the University of Texas M. D. Anderson Cancer Center for a newly diagnosed primary or metastatic brain tumor located in or adjacent to motor brain areas | 1 | [
"undergoing",
"a",
"tumor",
"resection",
"at",
"the",
"University",
"of",
"Texas",
"M.",
"D.",
"Anderson",
"Cancer",
"Center",
"for",
"a",
"newly",
"diagnosed",
"primary",
"or",
"metastatic",
"brain",
"tumor",
"located",
"in",
"or",
"adjacent",
"to",
"motor",
"brain",
"areas"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02442297 | 19:34:treatment | Subjects having a tumor resection if medically feasible | 1 | [
"Subjects",
"having",
"a",
"tumor",
"resection",
"if",
"medically",
"feasible"
] | [
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT00924027 | 1:21:cancer,64:76:treatment | gynecological cancer patients who may have received concurrent chemotherapy as a component of their treatment regimen | 1 | [
"gynecological",
"cancer",
"patients",
"who",
"may",
"have",
"received",
"concurrent",
"chemotherapy",
"as",
"a",
"component",
"of",
"their",
"treatment",
"regimen"
] | [
3,
3,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT03181126 | ,73:85:treatment | Refractory is defined as persistent disease after at least 2 courses of chemotherapy | 1 | [
"Refractory",
"is",
"defined",
"as",
"persistent",
"disease",
"after",
"at",
"least",
"2",
"courses",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03153410 | 33:45:treatment, | Must have received last dose of chemotherapy at least 14 days or longer prior to entry into the study | 1 | [
"Must",
"have",
"received",
"last",
"dose",
"of",
"chemotherapy",
"at",
"least",
"14",
"days",
"or",
"longer",
"prior",
"to",
"entry",
"into",
"the",
"study"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03139227 | ,,47:59:treatment | Must be > 1 year from pregnancy, lactation or chemotherapy | 1 | [
"Must",
"be",
">",
"1",
"year",
"from",
"pregnancy",
",",
"lactation",
"or",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03088709 | ,78:90:treatment | Less than twenty-one days have elapsed since the subject's last radiation or chemotherapy prior to conditioning | 1 | [
"Less",
"than",
"twenty-one",
"days",
"have",
"elapsed",
"since",
"the",
"subject",
"'s",
"last",
"radiation",
"or",
"chemotherapy",
"prior",
"to",
"conditioning"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT03082612 | 42:54:treatment | Have completed surgery with no plans for chemotherapy | 1 | [
"Have",
"completed",
"surgery",
"with",
"no",
"plans",
"for",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03082612 | 46:58:treatment | Treatment plans to include weekly outpatient chemotherapy | 1 | [
"Treatment",
"plans",
"to",
"include",
"weekly",
"outpatient",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
1
] |
NCT03051321 | 8:20:treatment | Active chemotherapy | 1 | [
"Active",
"chemotherapy"
] | [
0,
1
] |
NCT03011684 | 19:31:treatment | Has not yet begun chemotherapy | 1 | [
"Has",
"not",
"yet",
"begun",
"chemotherapy"
] | [
0,
0,
0,
0,
1
] |
NCT02913430 | 29:41:treatment | More than one prior line of chemotherapy in the metastatic setting | 1 | [
"More",
"than",
"one",
"prior",
"line",
"of",
"chemotherapy",
"in",
"the",
"metastatic",
"setting"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02912572 | 33:45:treatment | patients who have only received chemotherapy in the adjuvant setting | 1 | [
"patients",
"who",
"have",
"only",
"received",
"chemotherapy",
"in",
"the",
"adjuvant",
"setting"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02862938 | 19:31:treatment | Participant is on chemotherapy | 1 | [
"Participant",
"is",
"on",
"chemotherapy"
] | [
0,
0,
0,
1
] |
NCT02793583 | 1:13:treatment | chemotherapy | 1 | [
"chemotherapy"
] | [
1
] |
NCT02774421 | 28:40:treatment | who have been treated with chemotherapy at time of recurrence | 1 | [
"who",
"have",
"been",
"treated",
"with",
"chemotherapy",
"at",
"time",
"of",
"recurrence"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02759146 | 12:24:treatment | Undergoing chemotherapy | 1 | [
"Undergoing",
"chemotherapy"
] | [
0,
1
] |
NCT02758847 | 1:13:treatment | chemotherapy | 1 | [
"chemotherapy"
] | [
1
] |
NCT02658565 | 23:35:treatment | Patients who received chemotherapy directed at the present disease | 1 | [
"Patients",
"who",
"received",
"chemotherapy",
"directed",
"at",
"the",
"present",
"disease"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02639208 | 79:91:treatment | either in the context of standard treatment or a clinical trial and including chemotherapy | 1 | [
"either",
"in",
"the",
"context",
"of",
"standard",
"treatment",
"or",
"a",
"clinical",
"trial",
"and",
"including",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02635360 | 1:13:treatment | chemotherapy | 1 | [
"chemotherapy"
] | [
1
] |
NCT02603757 | 29:41:treatment | Patients who do not undergo chemotherapy | 1 | [
"Patients",
"who",
"do",
"not",
"undergo",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
1
] |
NCT02589938 | 11:23:treatment | Receiving chemotherapy during study period | 1 | [
"Receiving",
"chemotherapy",
"during",
"study",
"period"
] | [
0,
1,
0,
0,
0
] |
NCT02565498 | 9:21:treatment | Planned chemotherapy for (neo)adjuvant treatment | 1 | [
"Planned",
"chemotherapy",
"for",
"(",
"neo",
")",
"adjuvant",
"treatment"
] | [
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02562716 | ,,,151:163:treatment | women/men of reproductive potential must have agreed to use an effective contraceptive method for up to 3 months after the final administered dose of chemotherapy | 1 | [
"women/men",
"of",
"reproductive",
"potential",
"must",
"have",
"agreed",
"to",
"use",
"an",
"effective",
"contraceptive",
"method",
"for",
"up",
"to",
"3",
"months",
"after",
"the",
"final",
"administered",
"dose",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02536794 | 23:35:treatment | Patients who have had chemotherapy | 1 | [
"Patients",
"who",
"have",
"had",
"chemotherapy"
] | [
0,
0,
0,
0,
1
] |
NCT02536794 | ,36:48:treatment | have received at least one line of chemotherapy in the metastatic setting | 1 | [
"have",
"received",
"at",
"least",
"one",
"line",
"of",
"chemotherapy",
"in",
"the",
"metastatic",
"setting"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02492867 | 37:49:treatment | Patients cannot tolerate concurrent chemotherapy | 1 | [
"Patients",
"can",
"not",
"tolerate",
"concurrent",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
1
] |
NCT02481765 | 66:78:treatment | Intensive medical treatment means that the subject is undergoing chemotherapy for a hematologic/oncologic condition, is carrying a pacemaker or has been diagnosed with a cardiac anomaly which causes cardiac insufficiency not compensated with medications | 1 | [
"Intensive",
"medical",
"treatment",
"means",
"that",
"the",
"subject",
"is",
"undergoing",
"chemotherapy",
"for",
"a",
"hematologic/oncologic",
"condition",
",",
"is",
"carrying",
"a",
"pacemaker",
"or",
"has",
"been",
"diagnosed",
"with",
"a",
"cardiac",
"anomaly",
"which",
"causes",
"cardiac",
"insufficiency",
"not",
"compensated",
"with",
"medications"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02427841 | ,,,,156:168:treatment,,, | Women of child-bearing potential and men must be willing to use adequate contraception during the entire study and for 8 weeks following completion of all chemotherapy on study; this includes hormonal or barrier method, or abstinence | 1 | [
"Women",
"of",
"child-bearing",
"potential",
"and",
"men",
"must",
"be",
"willing",
"to",
"use",
"adequate",
"contraception",
"during",
"the",
"entire",
"study",
"and",
"for",
"8",
"weeks",
"following",
"completion",
"of",
"all",
"chemotherapy",
"on",
"study",
";",
"this",
"includes",
"hormonal",
"or",
"barrier",
"method",
",",
"or",
"abstinence"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02416206 | ,43:55:treatment | Within 9 months of the start of induction chemotherapy and no evidence of relapse or progression | 1 | [
"Within",
"9",
"months",
"of",
"the",
"start",
"of",
"induction",
"chemotherapy",
"and",
"no",
"evidence",
"of",
"relapse",
"or",
"progression"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02359825 | 12:24:treatment | undergoing chemotherapy | 1 | [
"undergoing",
"chemotherapy"
] | [
0,
1
] |
NCT02320292 | 19:31:treatment | No indication for chemotherapy | 1 | [
"No",
"indication",
"for",
"chemotherapy"
] | [
0,
0,
0,
1
] |
NCT02315196 | ,81:93:treatment | imaging must have been performed no greater than 30 days prior to initiation of chemotherapy | 1 | [
"imaging",
"must",
"have",
"been",
"performed",
"no",
"greater",
"than",
"30",
"days",
"prior",
"to",
"initiation",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02309892 | 10:22:treatment | Previous chemotherapy | 1 | [
"Previous",
"chemotherapy"
] | [
0,
1
] |
NCT02308709 | 12:24:treatment | Concurrent chemotherapy is allowed, but not required | 1 | [
"Concurrent",
"chemotherapy",
"is",
"allowed",
",",
"but",
"not",
"required"
] | [
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02303977 | ,41:53:treatment | Pregnant or breast-feeding patients, as chemotherapy is thought to present substantial risk to the fetus/infant | 1 | [
"Pregnant",
"or",
"breast-feeding",
"patients",
",",
"as",
"chemotherapy",
"is",
"thought",
"to",
"present",
"substantial",
"risk",
"to",
"the",
"fetus/infant"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02227199 | 54:66:treatment | Patients must be anticipated to complete 2 cycles of chemotherapy | 1 | [
"Patients",
"must",
"be",
"anticipated",
"to",
"complete",
"2",
"cycles",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02203513 | ,147:159:treatment | Patients should have recurrent platinum-resistant, defined as disease recurrence by imaging within 6 months of the last receipt of platinum-based chemotherapy | 1 | [
"Patients",
"should",
"have",
"recurrent",
"platinum-resistant",
",",
"defined",
"as",
"disease",
"recurrence",
"by",
"imaging",
"within",
"6",
"months",
"of",
"the",
"last",
"receipt",
"of",
"platinum-based",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02159703 | 7:19:treatment, | Prior chemotherapy within the past 5 years | 1 | [
"Prior",
"chemotherapy",
"within",
"the",
"past",
"5",
"years"
] | [
0,
1,
0,
0,
0,
0,
0
] |
NCT02153229 | ,62:74:treatment | Subjects who have received more than 2 doses of neo-adjuvant chemotherapy | 1 | [
"Subjects",
"who",
"have",
"received",
"more",
"than",
"2",
"doses",
"of",
"neo-adjuvant",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02135588 | ,40:52:treatment | At least 2 days from administration of chemotherapy | 1 | [
"At",
"least",
"2",
"days",
"from",
"administration",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02128906 | ,,53:65:treatment | Pregnant women are excluded from this study because chemotherapy | 1 | [
"Pregnant",
"women",
"are",
"excluded",
"from",
"this",
"study",
"because",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02128906 | 24:36:treatment | breast feeding because chemotherapy | 1 | [
"breast",
"feeding",
"because",
"chemotherapy"
] | [
0,
0,
0,
1
] |
NCT02115295 | 74:86:treatment | Patient with documented hypersensitivity to any of the components of the chemotherapy program | 1 | [
"Patient",
"with",
"documented",
"hypersensitivity",
"to",
"any",
"of",
"the",
"components",
"of",
"the",
"chemotherapy",
"program"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02101736 | 21:33:treatment, | No myelosuppressive chemotherapy within 4 weeks of study entry | 1 | [
"No",
"myelosuppressive",
"chemotherapy",
"within",
"4",
"weeks",
"of",
"study",
"entry"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02099591 | 49:61:treatment | Patients currently receiving the first cycle of chemotherapy | 1 | [
"Patients",
"currently",
"receiving",
"the",
"first",
"cycle",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02091999 | 1:13:treatment | chemotherapy | 1 | [
"chemotherapy"
] | [
1
] |
NCT02037048 | ,40:52:treatment | for 90 days following the last dose of chemotherapy | 1 | [
"for",
"90",
"days",
"following",
"the",
"last",
"dose",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02031250 | 43:55:treatment | Patients must be able to receive protocol chemotherapy in the judgment of the treating Medical Oncologist | 1 | [
"Patients",
"must",
"be",
"able",
"to",
"receive",
"protocol",
"chemotherapy",
"in",
"the",
"judgment",
"of",
"the",
"treating",
"Medical",
"Oncologist"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01953900 | 53:65:treatment | Recovered from the acute toxic effects of all prior chemotherapy | 1 | [
"Recovered",
"from",
"the",
"acute",
"toxic",
"effects",
"of",
"all",
"prior",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01928589 | 73:85:treatment | Patient must have a Medical Oncology consult with the recommendation of chemotherapy | 1 | [
"Patient",
"must",
"have",
"a",
"Medical",
"Oncology",
"consult",
"with",
"the",
"recommendation",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01925573 | 58:70:treatment | 6 weeks since the completion of a nitrosourea-containing chemotherapy regimen | 1 | [
"6",
"weeks",
"since",
"the",
"completion",
"of",
"a",
"nitrosourea-containing",
"chemotherapy",
"regimen"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01919619 | ,,,,128:140:treatment, | diffusing capacity of the lung for carbon monoxide (DLCO) >= 40% within 3 months of study entry (or within 1 month if received chemotherapy within the past 3 months) | 1 | [
"diffusing",
"capacity",
"of",
"the",
"lung",
"for",
"carbon",
"monoxide",
"(",
"DLCO",
")",
">",
"=",
"40",
"%",
"within",
"3",
"months",
"of",
"study",
"entry",
"(",
"or",
"within",
"1",
"month",
"if",
"received",
"chemotherapy",
"within",
"the",
"past",
"3",
"months",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01901562 | 15:27:treatment, | Have received chemotherapy in the last 12 months | 1 | [
"Have",
"received",
"chemotherapy",
"in",
"the",
"last",
"12",
"months"
] | [
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT01896999 | 46:58:treatment | Patients must have relapsed after first line chemotherapy | 1 | [
"Patients",
"must",
"have",
"relapsed",
"after",
"first",
"line",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01871766 | ,189:201:treatment | Participants treated on this protocol in the low or intermediate risk arm who experience disease progression prior to week 13 will transfer to the high risk arm and proceed with high risk chemotherapy starting at week 1 of the protocol | 1 | [
"Participants",
"treated",
"on",
"this",
"protocol",
"in",
"the",
"low",
"or",
"intermediate",
"risk",
"arm",
"who",
"experience",
"disease",
"progression",
"prior",
"to",
"week",
"13",
"will",
"transfer",
"to",
"the",
"high",
"risk",
"arm",
"and",
"proceed",
"with",
"high",
"risk",
"chemotherapy",
"starting",
"at",
"week",
"1",
"of",
"the",
"protocol"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01859819 | 13:25:treatment | No previous chemotherapy | 1 | [
"No",
"previous",
"chemotherapy"
] | [
0,
0,
1
] |
NCT01807091 | ,,,87:99:treatment | Treatment-related mortality (TRM) score < 9.21 corresponding to a TRM rate of 3% when chemotherapy of similar intensity as proposed here is administered to inpatients | 1 | [
"Treatment-related",
"mortality",
"(",
"TRM",
")",
"score",
"<",
"9.21",
"corresponding",
"to",
"a",
"TRM",
"rate",
"of",
"3",
"%",
"when",
"chemotherapy",
"of",
"similar",
"intensity",
"as",
"proposed",
"here",
"is",
"administered",
"to",
"inpatients"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01754298 | 1:13:treatment | chemotherapy treatment | 1 | [
"chemotherapy",
"treatment"
] | [
1,
0
] |
NCT01730794 | 37:49:treatment | Immunosuppressed patients receiving chemotherapy | 1 | [
"Immunosuppressed",
"patients",
"receiving",
"chemotherapy"
] | [
0,
0,
0,
1
] |
NCT01703949 | ,63:75:treatment | Patients must be anticipated to complete at least 2 cycles of chemotherapy on study | 1 | [
"Patients",
"must",
"be",
"anticipated",
"to",
"complete",
"at",
"least",
"2",
"cycles",
"of",
"chemotherapy",
"on",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT01690468 | 31:43:treatment | At least one prior regimen of chemotherapy, with no maximum number of chemotherapy cycles | 1 | [
"At",
"least",
"one",
"prior",
"regimen",
"of",
"chemotherapy",
",",
"with",
"no",
"maximum",
"number",
"of",
"chemotherapy",
"cycles"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01676259 | 1:13:treatment | chemotherapy | 1 | [
"chemotherapy"
] | [
1
] |
NCT01620216 | 105:117:treatment | certain agents that prolong the corrected QT interval may be allowed but only after discussion with the chemotherapy pharmacist | 1 | [
"certain",
"agents",
"that",
"prolong",
"the",
"corrected",
"QT",
"interval",
"may",
"be",
"allowed",
"but",
"only",
"after",
"discussion",
"with",
"the",
"chemotherapy",
"pharmacist"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01614990 | 38:50:treatment | subjects may otherwise be undergoing chemotherapy | 1 | [
"subjects",
"may",
"otherwise",
"be",
"undergoing",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
1
] |
NCT01526603 | 43:55:treatment, | Patients who are delayed in consolidation chemotherapy beyond 8 weeks | 1 | [
"Patients",
"who",
"are",
"delayed",
"in",
"consolidation",
"chemotherapy",
"beyond",
"8",
"weeks"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT01526603 | 40:52:treatment | Recovery from last induction course of chemotherapy | 1 | [
"Recovery",
"from",
"last",
"induction",
"course",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
1
] |
NCT01515527 | 74:86:treatment | Patient with documented hypersensitivity to any of the components of the chemotherapy program | 1 | [
"Patient",
"with",
"documented",
"hypersensitivity",
"to",
"any",
"of",
"the",
"components",
"of",
"the",
"chemotherapy",
"program"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01505569 | 48:60:treatment | Timing: Recovery from last induction course of chemotherapy | 1 | [
"Timing",
":",
"Recovery",
"from",
"last",
"induction",
"course",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01434316 | 7:19:treatment | Prior chemotherapy | 1 | [
"Prior",
"chemotherapy"
] | [
0,
1
] |
NCT01238120 | 63:75:treatment | Patients with a neutropenic episode during the first cycle of chemotherapy or at high risk for a neutropenic episode during future chemotherapy cycles at the treating physicians discretion | 1 | [
"Patients",
"with",
"a",
"neutropenic",
"episode",
"during",
"the",
"first",
"cycle",
"of",
"chemotherapy",
"or",
"at",
"high",
"risk",
"for",
"a",
"neutropenic",
"episode",
"during",
"future",
"chemotherapy",
"cycles",
"at",
"the",
"treating",
"physicians",
"discretion"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01061515 | 41:53:treatment | All patients must be consented prior to chemotherapy | 1 | [
"All",
"patients",
"must",
"be",
"consented",
"prior",
"to",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01061515 | 53:65:treatment,,,, | Patients must have adequate renal function prior to chemotherapy defined as serum creatinine ≤ 2.0 mg/dl or creatinine clearance ≥60 ml.min/1.73 m² for patients with creatinine levels above 2.0 mg/dl | 1 | [
"Patients",
"must",
"have",
"adequate",
"renal",
"function",
"prior",
"to",
"chemotherapy",
"defined",
"as",
"serum",
"creatinine",
"≤",
"2.0",
"mg/dl",
"or",
"creatinine",
"clearance",
"≥60",
"ml.min/1.73",
"m²",
"for",
"patients",
"with",
"creatinine",
"levels",
"above",
"2.0",
"mg/dl"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01061515 | 21:33:treatment | have received prior chemotherapy | 1 | [
"have",
"received",
"prior",
"chemotherapy"
] | [
0,
0,
0,
1
] |
NCT01061515 | 105:117:treatment | must undergo a peritoneal scan documenting at least one working intraperitoneal port prior to receiving chemotherapy | 1 | [
"must",
"undergo",
"a",
"peritoneal",
"scan",
"documenting",
"at",
"least",
"one",
"working",
"intraperitoneal",
"port",
"prior",
"to",
"receiving",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT00911560 | ,,178:190:treatment | stage 4 with (any age) or without (>18 months old) MYCN amplification, MYCN-amplified stage 3 (unresectable; any age), MYCN-amplified stage 4S, or disease resistant to standard chemotherapy | 1 | [
"stage",
"4",
"with",
"(",
"any",
"age",
")",
"or",
"without",
"(",
">",
"18",
"months",
"old",
")",
"MYCN",
"amplification",
",",
"MYCN-amplified",
"stage",
"3",
"(",
"unresectable",
";",
"any",
"age",
")",
",",
"MYCN-amplified",
"stage",
"4S",
",",
"or",
"disease",
"resistant",
"to",
"standard",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT00902720 | 1:13:treatment | chemotherapy | 1 | [
"chemotherapy"
] | [
1
] |
NCT00819208 | 63:75:treatment | patients who are pre-planned to receive a shorter duration of chemotherapy, including as part of a research study | 1 | [
"patients",
"who",
"are",
"pre-planned",
"to",
"receive",
"a",
"shorter",
"duration",
"of",
"chemotherapy",
",",
"including",
"as",
"part",
"of",
"a",
"research",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00719888 | ,,97:109:treatment | ligible with (M2 marrow) with =< 25% blasts in marrow after having failed one or more cycles of chemotherapy | 1 | [
"ligible",
"with",
"(",
"M2",
"marrow",
")",
"with",
"=",
"<",
"25",
"%",
"blasts",
"in",
"marrow",
"after",
"having",
"failed",
"one",
"or",
"more",
"cycles",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT00719888 | ,81:93:treatment | patients persistently aplastic for greater than one month since completing last chemotherapy are also eligible with PI approval | 1 | [
"patients",
"persistently",
"aplastic",
"for",
"greater",
"than",
"one",
"month",
"since",
"completing",
"last",
"chemotherapy",
"are",
"also",
"eligible",
"with",
"PI",
"approval"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT00632853 | 1:13:treatment | chemotherapy | 1 | [
"chemotherapy"
] | [
1
] |
NCT00632853 | 115:127:treatment | patients also must have met all of the eligibility criteria in the protocol prior to receiving the first cycle of chemotherapy | 1 | [
"patients",
"also",
"must",
"have",
"met",
"all",
"of",
"the",
"eligibility",
"criteria",
"in",
"the",
"protocol",
"prior",
"to",
"receiving",
"the",
"first",
"cycle",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT00501826 | 36:48:treatment | failure to one induction course of chemotherapy are eligible | 1 | [
"failure",
"to",
"one",
"induction",
"course",
"of",
"chemotherapy",
"are",
"eligible"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT00492778 | 23:35:treatment | Patients who received chemotherapy directed at the present recurrence | 1 | [
"Patients",
"who",
"received",
"chemotherapy",
"directed",
"at",
"the",
"present",
"recurrence"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT00107289 | 52:64:treatment | Three weeks should have elapsed since last dose of chemotherapy | 1 | [
"Three",
"weeks",
"should",
"have",
"elapsed",
"since",
"last",
"dose",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02140554 | 22:32:cancer,36:61:chronic_disease | Any prior or current malignancy or immunodeficiency disorder | 1 | [
"Any",
"prior",
"or",
"current",
"malignancy",
"or",
"immunodeficiency",
"disorder"
] | [
0,
0,
0,
0,
3,
0,
2,
2
] |
NCT03171493 | 31:41:cancer | Patients with any other prior malignancy are not allowed | 1 | [
"Patients",
"with",
"any",
"other",
"prior",
"malignancy",
"are",
"not",
"allowed"
] | [
0,
0,
0,
0,
0,
3,
0,
0,
0
] |
NCT03158974 | 28:38:cancer, | Have evidence of an active malignancy or have been immunocompromised within the 60 days prior to Screening | 1 | [
"Have",
"evidence",
"of",
"an",
"active",
"malignancy",
"or",
"have",
"been",
"immunocompromised",
"within",
"the",
"60",
"days",
"prior",
"to",
"Screening"
] | [
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03158519 | 27:37:cancer | Diagnosis of other active malignancy | 1 | [
"Diagnosis",
"of",
"other",
"active",
"malignancy"
] | [
0,
0,
0,
0,
3
] |